EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Effect of Placental Mesenchymal Stromal Cells in an In Vitro Model of Parkinson’s Disease Using Differentiated Neuroblastoma Cells

Almudena Coto-Vilcapoma iD, Laura Sánchez-Carretero iD, Daniel Arenas-Gonzalez iD, José A Molina, María José Morán-Jiménez iD, José Joaquín Merino, Paz de la Torre iD, Ana I Flores iD

International Journal of Molecular Sciences · 28.04.2026 · 27 (9) · 3925

DOI: 10.3390/ijms27093925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.04.2026. Verfasst von Almudena Coto-Vilcapoma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Medicina Regenerativa, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Neuroblastoma, Cell Differentiation, Parkinson Disease. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Health Carlos III, MCIN/AEI/ 10.13039/501100011033, ASOCIACIÓN PARKINSON MADRID and FUNDACIÓN NEUROCIENCIAS Y ENVEJECIMIENTO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. It is characterized by the accumulation of misfolded α-synuclein (α-syn) and progressive loss of dopaminergic neurons in the substantia nigra. Due to the limitations of current therapies, mesenchymal stromal cell (MSC) transplantation has emerged as a promising neuroprotective strategy. This study evaluated the neuroprotective potential of decidua-derived mesenchymal stromal cells (DMSCs) in vitro using a human neuroblastoma cell line (NB69) exposed to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) as a PD model. The NB69 cells were differentiated into a mature dopaminergic phenotype using dibutyryl cyclic adenosine monophosphate (dbcAMP) and then exposed to MPP+. In proliferative NB69 cells, the effect of DMSCs was masked by their inherent antitumor activity against the neuroblastoma phenotype. Conversely, in the differentiated NB69 model, DMSCs demonstrated a significant protective role against MPP+-induced cytotoxicity. Interestingly, the mechanism by which DMSCs might exert a neuroprotective effect against MPP+ damage in differentiated NB69 cells appears to involve improving mitochondrial function by reducing free radicals. In summary, these findings suggest that DMSCs exert a neuroprotective effect in a dopaminergic-like context and highlight the importance of using differentiated cell models to accurately evaluate cell-based therapies for PD in the striatum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsNeuroblastomaCell DifferentiationParkinson DiseasePlacentaHumansFemaleCell Line, Tumor1-Methyl-4-phenylpyridiniumPregnancyDopaminergic NeuronsDecidua

Stichwörter der Autor:innen

1-methyl-4-phenylpyridiniumDMSCsMPP+NB69PDParkinsondbcAMPdecidua mesenchymal stromal cellsdibutyryl cyclic adenosine monophosphateneuroprotectionoxidative stressperinatal MSCsperinatal mesenchymal stromal cells

Substanzen

1-Methyl-4-phenylpyridinium

Autor:innen und Institutionen

  • Grupo de Medicina Regenerativa, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain.
  • Servicio de Neurología e Instituto de Investigación Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain.
  • Departamento de Farmacología, Farmacognosia y Botánica, Facultad de Farmacia, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.

ORCID-Profile: Almudena Coto-Vilcapoma, Laura Sánchez-Carretero, Daniel Arenas-Gonzalez, María José Morán-Jiménez, Paz de la Torre, Ana I Flores

Förderung

  • Institute of Health Carlos III
  • MCIN/AEI/ 10.13039/501100011033
  • ASOCIACIÓN PARKINSON MADRID and FUNDACIÓN NEUROCIENCIAS Y ENVEJECIMIENTO
  • FUNDACIÓN FRANCISCO SORIA MELGUIZO

Zitieren

APA

Coto-Vilcapoma, A., Sánchez-Carretero, L., Arenas-Gonzalez, D., Molina, J. A., Morán-Jiménez, M. J., Merino, J. J., Torre, P., & Flores, A. I. (2026). Protective Effect of Placental Mesenchymal Stromal Cells in an In Vitro Model of Parkinson’s Disease Using Differentiated Neuroblastoma Cells. International Journal of Molecular Sciences, 27(9), 3925. https://doi.org/10.3390/ijms27093925

Vancouver

Coto-Vilcapoma A, Sánchez-Carretero L, Arenas-Gonzalez D, Molina JA, Morán-Jiménez MJ, Merino JJ, et al. Protective Effect of Placental Mesenchymal Stromal Cells in an In Vitro Model of Parkinson’s Disease Using Differentiated Neuroblastoma Cells. International Journal of Molecular Sciences. 2026;27(9):3925. doi:10.3390/ijms27093925

BibTeX
@article{CotoVilcapoma2026,
  author = {Coto-Vilcapoma, Almudena and Sánchez-Carretero, Laura and Arenas-Gonzalez, Daniel and Molina, José A and Morán-Jiménez, María José and Merino, José Joaquín and Torre, Paz de la and Flores, Ana I},
  title = {Protective Effect of Placental Mesenchymal Stromal Cells in an In Vitro Model of Parkinson’s Disease Using Differentiated Neuroblastoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3925},
  doi = {10.3390/ijms27093925}
}
Kostenlos starten →